A previous study using the same genetically engineered prostate cancer model demonstrated that oral administration of an antibiotic mixture in prostate cancer–bearing mice fed with an HFD altered the composition of the gut microbiota and inhibited prostate cancer cell proliferation with the modulation of prostate IGF-1 expression [18]. Here, IGF1 is linked to prostate cancer.